EUR 10.2
(-1.92%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 26.97 Million | 26.8 Million | 29.53 Million | 87.84 Million | 24.15 Million | -67.74 Million |
Net Income | 19.05 Million | -15.88 Million | 178.24 Million | 85.58 Million | 155.74 Million | 50.49 Million |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -16.1 Million | 48.73 Million | -9.58 Million | -12.08 Million | 31.76 Million | -13.39 Million |
Other non-cash items | 24.02 Million | -6.04 Million | -139.13 Million | 14.34 Million | -163.35 Million | -104.84 Million |
Investing Cash Flow | 46.74 Million | 68 Million | 108.59 Million | 113.43 Million | 33.92 Million | -28.54 Million |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -5.78 Million | -155.35 Million | -306.09 Million | -55.91 Million | -45.21 Million | -153.36 Million |
Sales/Maturities of investments | 52.52 Million | 223.35 Million | 414.69 Million | 169.34 Million | 79.13 Million | 124.82 Million |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | -32.06 Million | -52.86 Million | -21.52 Million | -78.66 Million | -28.05 Million | -3.82 Million |
Debt repayment | -30.2 Million | -133 Million | -49.25 Million | -115.95 Million | -12.5 Million | -35 Million |
Dividends payments | -50.48 Million | -26.27 Million | -46.33 Million | -30.08 Million | -40.1 Million | -38.72 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 48.61 Million | 106.41 Million | 74.05 Million | 67.36 Million | 24.55 Million | 69.89 Million |
Accounts receivables | -429 Thousand | -8.55 Million | -47.73 Million | -16.41 Million | 16.87 Million | -15.96 Million |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -405 Thousand | 57.29 Million | 38.15 Million | 4.33 Million | 14.89 Million | 2.57 Million |
Cash at beginning of period | 14.85 Million | 40.15 Million | 31.51 Million | 22.57 Million | 26.49 Million | 97.41 Million |
Cash at end of period | 9.74 Million | 14.85 Million | 40.15 Million | 31.51 Million | 22.57 Million | 26.49 Million |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | -17 Thousand | 754 Thousand | 635 Thousand | -236 Thousand | -30 Thousand | 649 Thousand |
Net cash flow / Change in cash | -5.1 Million | -25.3 Million | 8.64 Million | 8.94 Million | -3.92 Million | -70.91 Million |
Free Cash Flow | 26.97 Million | 26.8 Million | 29.53 Million | 87.84 Million | 24.15 Million | -67.74 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 19.87 Million | 19.87 Million | -8.35 Million | 19.05 Million | -8.35 Million | 17.56 Million |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -401 Thousand | -401 Thousand | 367 Thousand | -16.1 Million | 367 Thousand | -784 Thousand |
Other non-cash items | 10.32 Million | 10.32 Million | 19.92 Million | 24.02 Million | 19.92 Million | -15.23 Million |
Investing Cash Flow | - | - | 38.07 Million | 46.74 Million | - | 8.67 Million |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | -690.99 Thousand | -5.78 Million | - | -5.09 Million |
Sales/Maturities of investments | - | - | 38.76 Million | 52.52 Million | - | 13.76 Million |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | -22.28 Million | -22.28 Million | -9.62 Million | -32.06 Million | -9.62 Million | -6.4 Million |
Debt repayment | - | - | -6.49 Million | -30.2 Million | - | -12.5 Million |
Dividends payments | -12.27 Million | -12.27 Million | -12.62 Million | -50.48 Million | -12.62 Million | -12.62 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -10 Million | -10 Million | 2.99 Million | 48.61 Million | 2.99 Million | 6.21 Million |
Accounts receivables | -603.5 Thousand | -603.5 Thousand | 561 Thousand | -429 Thousand | 561 Thousand | -775.5 Thousand |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 202.5 Thousand | 202.5 Thousand | -194 Thousand | -405 Thousand | -194 Thousand | -8500.00 |
Cash at beginning of period | - | - | 5.11 Million | 14.85 Million | - | 40.15 Million |
Cash at end of period | 7.42 Million | 7.42 Million | 9.74 Million | 9.74 Million | 2.31 Million | 5.11 Million |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | -93 Thousand | -93 Thousand | -2500.00 | -17 Thousand | -2500.00 | -6000.00 |
Net cash flow / Change in cash | 7.42 Million | 7.42 Million | 4.62 Million | -5.1 Million | 2.31 Million | -35.04 Million |
Free Cash Flow | 29.8 Million | 29.8 Million | 11.94 Million | 26.97 Million | 11.94 Million | 1.54 Million |
3499
CTLPP
SPECIALITY
FDVA
ALPSINDUS
CLIR